Mustafa A. Zaman, Ph.D., joined Granzer Regulatory Consulting & Services GmbH as a Senior Consultant in November 2022. He qualified as a Pharmacist after initially gaining a BPharm (Hons) degree and later a PhD in Drug Delivery – both from King’s College London. With over 19 years’ experience he sees success as derived through efficiently interpreting, utilising, advocating and influencing current regulatory frameworks / policy / guidance in combination with developments to existing products and new innovations.

Mustafa A. Zaman spent almost 10 years working for the UK Medicines & Healthcare Products Regulatory Agency (MHRA), where his previous role was a Senior Pharmaceutical / CMC Assessor in Healthcare Quality and Access (HQA) responsible for evaluating, assessing and providing scientific advice on both UK (National) and European Marketing Authorisation Applications and post-approval variations, with a focus on small molecules.

He has worked with several international companies including PAREXEL International Consulting (UK), GSK (UK), GENPACT (UK), POLUS Inc. (South Korea) and Scendea Ltd (UK). Mustafa also holds four academic (Honorary) posts at three UK Universities.

Mustafa A. Zaman has experience in leading strategic, technical and / or process issues for a wide range of therapeutic areas and product types, including new chemical entities, generic products, combination products, drug-device combinations and clinical trials applications. He is experienced in European and US procedures concerning meetings with regulatory authorities, Clinical Trial Applications (CTAs, IMPDs, INDs), and Market Authorizations’ (MAAs, NDAs).